Legend Biotech (LEGN) Inventory Average (2020 - 2025)
Legend Biotech (LEGN) reported Inventory Average of $30.6 million for Q4 2025, up 28.95% on a YoY basis from $23.7 million in Q4 2024, and down 5.54% quarter-over-quarter from $32.4 million in Q3 2025.
Legend Biotech (LEGN) Inventory Average (2020 - 2025) Analysis & Trends
Legend Biotech has reported Inventory Average for 6 years, with the latest figure at $30.6 million in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average rose 28.95% year-over-year to $30.6 million; the trailing twelve-month figure through Dec 2025 stood at $30.6 million (up 28.95% YoY), and the FY2025 full-year result was $28.0 million, up 29.0% from the prior year.
- Inventory Average for Q4 2025 stood at $30.6 million, down from $32.4 million in the prior quarter.
- The five-year high for Inventory Average was $33.3 million in Q2 2025, with the low at $1898.5 in Q2 2021.
- Historically, Inventory Average has averaged $16.2 million across 5 years, with a median of $18.7 million in 2023.
- Annual changes were most pronounced in 2021 — Inventory Average surged 51320.94% — and 2024, when it climbed 26.71%.
- Legend Biotech's Inventory Average stood at $1.7 million in 2021, then surged by 37.27% to $2.3 million in 2022, then soared by 706.35% to $18.7 million in 2023, then rose by 26.71% to $23.7 million in 2024, then increased by 28.95% to $30.6 million in 2025.
- The last three Inventory Average figures came in at $30.6 million (Q4 2025), $32.4 million (Q3 2025), and $33.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 3.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.59 Mn |
| Sep 30, 2025 | 32.39 Mn |
| Jun 30, 2025 | 33.26 Mn |
| Mar 31, 2025 | 27.42 Mn |
| Dec 31, 2024 | 23.72 Mn |
| Sep 30, 2024 | 21.21 Mn |
| Jun 30, 2024 | 20.51 Mn |
| Mar 31, 2024 | 20.79 Mn |
| Dec 31, 2023 | 18.72 Mn |
| Sep 30, 2023 | 16.61 Mn |
| Jun 30, 2023 | 13.69 Mn |
| Mar 31, 2023 | 11.27 Mn |
| Mar 31, 2022 | 2.32 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 817,850.00 |
| Jun 30, 2021 | 1,898.50 |
| Mar 31, 2021 | 901,048.50 |
| Dec 31, 2020 | 900,756.50 |
| Sep 30, 2020 | 1,590.50 |